nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—CYP3A4—bone cancer	0.99	1	CbGaD
Levomethadyl Acetate—Disopyramide—CYP3A4—bone cancer	0.000658	0.175	CrCbGaD
Levomethadyl Acetate—Modafinil—CYP3A4—bone cancer	0.000469	0.124	CrCbGaD
Levomethadyl Acetate—Dextropropoxyphene—CYP3A4—bone cancer	0.000464	0.123	CrCbGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—FEV—bone cancer	0.000443	0.0752	CbGpPWpGaD
Levomethadyl Acetate—Loperamide—CYP3A4—bone cancer	0.000442	0.117	CrCbGaD
Levomethadyl Acetate—CYP19A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000436	0.0739	CbGpPWpGaD
Levomethadyl Acetate—Benzphetamine—CYP3A4—bone cancer	0.000407	0.108	CrCbGaD
Levomethadyl Acetate—Phenoxybenzamine—CYP3A4—bone cancer	0.000389	0.103	CrCbGaD
Levomethadyl Acetate—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000378	0.0642	CbGpPWpGaD
Levomethadyl Acetate—Tamoxifen—CYP3A4—bone cancer	0.000317	0.0842	CrCbGaD
Levomethadyl Acetate—Methadone—CYP3A4—bone cancer	0.000315	0.0835	CrCbGaD
Levomethadyl Acetate—Orphenadrine—CYP3A4—bone cancer	0.000308	0.0818	CrCbGaD
Levomethadyl Acetate—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000273	0.0464	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—CYP4V2—bone cancer	0.000187	0.0318	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000183	0.031	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000176	0.0298	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000163	0.0276	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000137	0.0233	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000132	0.0224	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000127	0.0216	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000127	0.0215	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00012	0.0203	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000118	0.02	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Tryptophan metabolism—CYP3A4—bone cancer	0.000108	0.0183	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	9.06e-05	0.0154	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Ovarian Infertility Genes—CDK4—bone cancer	8.95e-05	0.0152	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	8.73e-05	0.0148	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	8.62e-05	0.0146	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	7.58e-05	0.0129	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	7.48e-05	0.0127	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	7.08e-05	0.012	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	6.87e-05	0.0117	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	6.15e-05	0.0104	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—GRM4—bone cancer	5.84e-05	0.0099	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—RGS1—bone cancer	5.84e-05	0.0099	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	5.48e-05	0.00929	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	5.47e-05	0.00928	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	5.41e-05	0.00917	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	5.24e-05	0.00889	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Tryptophan metabolism—MDM2—bone cancer	4.96e-05	0.00842	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	4.79e-05	0.00813	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	4.44e-05	0.00753	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	4.39e-05	0.00745	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—ATF1—bone cancer	4.28e-05	0.00726	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	4.12e-05	0.00698	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	4.02e-05	0.00681	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—BRAF—bone cancer	3.94e-05	0.00668	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—CYP3A4—bone cancer	3.76e-05	0.00638	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—CYP3A4—bone cancer	3.71e-05	0.00629	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—BRAF—bone cancer	3.6e-05	0.00611	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	3.57e-05	0.00605	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—GRM4—bone cancer	3.53e-05	0.00599	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—JUN—bone cancer	3.5e-05	0.00594	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	3.49e-05	0.00592	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—MDM2—bone cancer	3.3e-05	0.0056	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—CYP3A4—bone cancer	3.26e-05	0.00554	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	3.22e-05	0.00546	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—GSTP1—bone cancer	3.22e-05	0.00545	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—GSTP1—bone cancer	3.17e-05	0.00538	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—GRM1—bone cancer	3.06e-05	0.0052	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—MDM2—bone cancer	3.02e-05	0.00512	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—BRAF—bone cancer	3.02e-05	0.00512	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—GSTP1—bone cancer	2.79e-05	0.00474	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—BRAF—bone cancer	2.76e-05	0.00468	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	2.75e-05	0.00467	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—bone cancer	2.59e-05	0.00439	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—TCR Signaling Pathway—JUN—bone cancer	2.55e-05	0.00432	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—MDM2—bone cancer	2.53e-05	0.00429	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—CYP3A4—bone cancer	2.36e-05	0.004	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	2.33e-05	0.00395	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—MDM2—bone cancer	2.31e-05	0.00392	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—bone cancer	2.29e-05	0.00388	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NDUFA12—bone cancer	2.25e-05	0.00382	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—RB1—bone cancer	2.25e-05	0.00381	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—SMO—bone cancer	2.16e-05	0.00366	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—GSTP1—bone cancer	2.02e-05	0.00342	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—RGS1—bone cancer	2e-05	0.00339	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—GRM4—bone cancer	2e-05	0.00339	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	1.99e-05	0.00338	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NDUFA12—bone cancer	1.96e-05	0.00332	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—bone cancer	1.92e-05	0.00325	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—NT5C3A—bone cancer	1.87e-05	0.00317	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—RGS1—bone cancer	1.81e-05	0.00308	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—GRM4—bone cancer	1.81e-05	0.00308	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—GRM1—bone cancer	1.73e-05	0.00294	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—JUN—bone cancer	1.67e-05	0.00283	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—NT5C3A—bone cancer	1.62e-05	0.00275	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—GRM1—bone cancer	1.57e-05	0.00267	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	1.45e-05	0.00246	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NDUFA12—bone cancer	1.41e-05	0.0024	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bone cancer	1.31e-05	0.00222	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—NT5C3A—bone cancer	1.17e-05	0.00199	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—GNA11—bone cancer	1.12e-05	0.00189	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—SMO—bone cancer	1.11e-05	0.00188	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—bone cancer	1.1e-05	0.00187	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GRM4—bone cancer	1.07e-05	0.00182	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—RGS1—bone cancer	1.07e-05	0.00182	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—GNA11—bone cancer	1.01e-05	0.00172	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—IL3—bone cancer	1.01e-05	0.00172	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTP1—bone cancer	9.38e-06	0.00159	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GRM1—bone cancer	9.29e-06	0.00158	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	9.25e-06	0.00157	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—IL3—bone cancer	9.19e-06	0.00156	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—ENO2—bone cancer	8.18e-06	0.00139	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—DHFR—bone cancer	7.59e-06	0.00129	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—ENO2—bone cancer	7.1e-06	0.0012	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GNA11—bone cancer	7.09e-06	0.0012	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—DHFR—bone cancer	6.59e-06	0.00112	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NDUFA12—bone cancer	6.58e-06	0.00112	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SMO—bone cancer	6.55e-06	0.00111	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CYP3A4—bone cancer	6.43e-06	0.00109	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.4e-06	0.00108	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GNA11—bone cancer	6.16e-06	0.00104	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GNA11—bone cancer	5.99e-06	0.00102	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CYP3A4—bone cancer	5.58e-06	0.000947	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ATF1—bone cancer	5.57e-06	0.000944	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTP1—bone cancer	5.5e-06	0.000933	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—NT5C3A—bone cancer	5.45e-06	0.000924	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IL3—bone cancer	5.43e-06	0.000921	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—ENO2—bone cancer	5.13e-06	0.000871	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTP1—bone cancer	4.77e-06	0.00081	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—DHFR—bone cancer	4.76e-06	0.000808	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TGFBR2—bone cancer	4.64e-06	0.000787	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GNA11—bone cancer	4.45e-06	0.000755	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1R—bone cancer	4.37e-06	0.000741	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CYP3A4—bone cancer	4.04e-06	0.000684	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTP1—bone cancer	3.45e-06	0.000585	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—KIT—bone cancer	3.17e-06	0.000537	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—BRAF—bone cancer	2.98e-06	0.000505	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—EGFR—bone cancer	2.89e-06	0.000489	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS2—bone cancer	2.85e-06	0.000483	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MDM2—bone cancer	2.49e-06	0.000423	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS2—bone cancer	2.47e-06	0.00042	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—ENO2—bone cancer	2.39e-06	0.000405	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DHFR—bone cancer	2.21e-06	0.000376	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—JUN—bone cancer	2.17e-06	0.000368	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MMP9—bone cancer	2.11e-06	0.000358	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GNA11—bone cancer	2.07e-06	0.000351	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS2—bone cancer	1.79e-06	0.000303	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—EGFR—bone cancer	1.7e-06	0.000289	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTP1—bone cancer	1.6e-06	0.000272	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TP53—bone cancer	1.43e-06	0.000243	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS2—bone cancer	8.31e-07	0.000141	CbGpPWpGaD
